Aggressive Pursuit of No Evidence of Disease Status in Hepatoblastoma Improves Survival
hosted by Dr. Cecilia Giquena · StayCurrentMD
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and Hepatoblastoma
1 min · Published Jan 2026
Video
Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma
1 min · Published Jan 2026
Video
BOB Ped Surg 2023 - Andrew Fleming, AAP - Presentation
Published Feb 2023
Video
Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
1 min · Published Jan 2026
Video
Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma
1 min · Published Jan 2026
Video
Early Postoperative Fever in Pediatric Oncology Patients Undergoing Solid Tumor Resection
51 s · Published Dec 2025
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
What the experts said
The study was a retrospective observational study conducted at Cincinnati Children's Hospital from 2005 to 2021
The study aim was to examine the effect of aggressive pursuit of no evidence of disease status on overall survival and event free status
The study included 50 patients with hepatoblastoma
41 patients were rendered to no evidence of disease status
Overall survival and event free status were significantly improved in both high risk and non-high risk patients who achieved no evidence of disease status
Pursuing no evidence of disease status is better for overall survival in hepatoblastoma patients